檢索結果 - Silvio Nadalin
- Showing 1 - 20 results of 56
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Transforming Growth Factor-β (TGF-β)-mediated Connective Tissue Growth Factor (CTGF) Expression in Hepatic Stellate Cells Requires Stat3 Signaling Activation 由 Yan Liu, Heng Liu, Christoph Meyer, Jun Li, Silvio Nadalin, Alfred Königsrainer, Honglei Weng, Steven Dooley, Peter ten Dijke
出版 2013Artigo -
14
-
15
-
16
-
17
Preoperative Volume Prediction in Adult Living Donor Liver Transplantation: How Much Can We Rely on It? Essen Experience Based on Virtual Three-dimensional Computed Tomography-Volu... 由 A. Radtke, G. Sotiropoulos, Silvio Nadalin, EP Molmenti, T. Schroeder, Hauke Lang, Fuat H. Saner, C Valentín-Gamazo, Andrea Frilling, Andrea Schenk, CE Broelscha, Massimo Malagó
出版 2007Artigo -
18
Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis: Is Clinical Tumor Classification before Transplantation Realistic? 由 Georgios C. Sotiropoulos, Massimo Malag�, Ernesto P. Molmenti, Andreas Paul, Silvio Nadalin, Eirini I. Brokalaki, Hilmar K hl, Olaf Dirsch, Hauke Lang, Christoph E. Broelsch
出版 2005Artigo -
19
-
20
Preoperative donor liver biopsy for adult living donor liver transplantation: Risks and benefits 由 Silvio Nadalin, Massimo Malagó, C Valentín-Gamazo, Giuliano Testa, Hideo A. Baba, Chao Liu, Nils R. Frühauf, Randolph Schaffer, Guido Gerken, Andrea Frilling, Christoph E. Broelsch
出版 2005Artigo
相關主題
Medicine
Internal medicine
Surgery
Transplantation
Liver transplantation
Biology
Gastroenterology
Cohort
Confidence interval
Disease
Hepatectomy
Oncology
Resection
Cirrhosis
Endocrinology
Paleontology
Cancer
Intensive care medicine
Liver disease
Physics
Radiology
Randomized controlled trial
Stage (stratigraphy)
Clinical endpoint
Hazard ratio
Hepatocellular carcinoma
Immunosuppression
Living donor liver transplantation
Urology
Diabetes mellitus